Transl Clin Pharmacol.  2018 Sep;26(3):101-102. 10.12793/tcp.2018.26.3.101.

Regional clinical pharmacology trials for Multi-Regional clinical trials

• Jang IJ

• KMID: 2420290
• DOI: http://doi.org/10.12793/tcp.2018.26.3.101

Abstract

No abstract available.

MeSH Terms

Pharmacology, Clinical*

Figure

• 

  Figure 1 Illustrations of clinical drug development workflow across regions for drug submission and regulatory review in independent and global strategies.[2] *Marketing Authorization Application/New Drug Application, **Could be parallel single region trials or MRCTs.

Reference

1. General principles for planning and design of Multi-Regional Clinical Trials. Accessed 1 July 2018. http://www.ich.org/products/guidelines/efficacy/efficacy-single/article/general-principle-on-planningdesigning-multi-regional-clinical-trials.html/.

2. ICH E17. Accessed 1 July 2018. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E17/E17EWG_Step4_2017_1116.pdf/.

3. Construction of Northeast Asian network. Accessed 1 July 2018. https://www.konect.or.kr/kr/contents/business_new_6/view.do/.

4. Hasunuma T, Tohkin M, Kaniwa N, Jang IJ, Yimin C, Kaneko M, et al. Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians. Br J Clin Pharmacol. 2016; 81:1078–1090. DOI: 10.1111/bcp.12884.

5. Jeon H, Jang IJ, Lee S, Ohashi K, Kotegawa T, Ieiri I, et al. Apple juice greatly reduces systemic exposure to atenolol. Br J Clin Pharmacol. 2013; 75:172–179. DOI: 10.1111/j.1365-2125.2012.04324.x.

6. Hor SY, Lee SC, Wong CI, Lim YW, Lim RC, Wang LZ, et al. PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients. Pharmacogenomics J. 2008; 8:139–146.

7. Tamura M, Kondo M, Horio M, Ando M, Saito H, Yamamoto M, et al. Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (ABCG2, ABCB1) and gefitinib toxicity. Nagoya J Med Sci. 2012; 74:133–140.

8. Arnold FL, Fukunaga S, Kusama M, Matsuki N, Ono S. Assessment of factors associated with dose differences between Japan and the United States. Clin Pharmacol Ther. 2014; 95:542–549. DOI: 10.1038/clpt.2013.231.